Replies to post #91084 on Ayala Pharmaceuticals Inc (ADXS)

[gajj]

I have tried repeatedly to obtain info from PETX re AT-014. They reiterate that they cannot provide what would be inside info. We do know they began enrollment in the final study mid Feb 2018 at 22 centers country wide. They will not say how long the study must last or when enrollment was completed but, given the prognosis sans treatment, one would think the study could not last more than one yr post full enrollment. If we take full enrollment by end of march/april then the study will likely be conclude end of april and we will have to wait for approval of the application by the USDA (post shutdown?)